NPI registry status
Active
2026 NPPES data Otolaryngology Physician NPI 1013960210 MD
Verify on CMS → Saul Modlin, MD
Otolaryngology Physician in Garden City, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,060 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
425
Medicare Part D claims · 197 beneficiaries · Otolaryngology Physician avg: 536
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$748.65
13 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Saul Modlin, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 425 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 425
- Part D claims, 2024
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Saul Modlin, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1013960210), first enumerated 05/18/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 425 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$748.65 in reported industry payments (13 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Saul Modlin, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1013960210 · Otolaryngology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1013960210
- ENUM-LEGACY 2006
- TAX-MID 11K Otolaryngology Physician
- MIPS-NEUTRAL 75/100
- RX-LIGHT 425
- BOOK-LIGHT 724 in New York
- PHOTO-ENUM Robert Burgess · 2006
Saul Modlin, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
425 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Saul Modlin, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Saul Modlin, MD?
CMS neutral score, not measuredPrimary specialty
Otolaryngology Physician
Medicare Part D claims
425 21% vs specialty avg
MIPS final score
75/100
Specialty distribution in New York
How Otolaryngology Physician compares to other specialties among New York providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1013960210 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/18/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Saul Modlin, MD. Source: openpaymentsdata.cms.gov.
Total received
$749
Largest payer
Genentech USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Saul Modlin, MD. To verify Saul Modlin, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Saul Modlin, MD - brand share 3.0%
Otolaryngology Physician average
3% brand-name claims vs 97% generic, on 425 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
425
Total Claims
$81K
Total Drug Cost
197
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 720.067
- Total Day Supply
- 20,110
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $63K
- Generic Drug Cost
- $18K
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 77.3 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 13, 65-74: 67, 75-84: 71, 85+: 46
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Saul Modlin, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ipratropium Bromide
Ipratropium Bromide
238 claims
- Pantoprazole Sodium 46
Pantoprazole Sodium
46 claims
- Ofloxacin 30
Ofloxacin
30 claims
- Fluticasone Propio… 27
Fluticasone Propionate
27 claims
- Doxycycline Hyclate 13
Doxycycline Hyclate
13 claims
| Drug | Claims |
|---|---|
| Ipratropium Bromide | 238 |
| Pantoprazole Sodium | 46 |
| Ofloxacin | 30 |
| Fluticasone Propionate | 27 |
| Doxycycline Hyclate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How Saul Modlin, MD fits within the Otolaryngology Physician landscape nationally.
11,060
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
536
Avg Claims per Provider
Saul Modlin, MD's 425 claims are below the specialty average of 536.
Nationwide Otolaryngology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Modlin, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Modlin.
One of 724 Otolaryngology Physician providers enrolled in New York, 5 are shown here.
Dr. Michel Abboud
MD
New York, NY
Dr. Allan Abramson
MD
New Hyde Park, NY
Sara Abu Ghanem
Brooklyn, NY
Dr. Benjamin Acker
D.O.
Port Jefferson Station, NY
Dr. Kayla Ackerman
MD
Oneida, NY
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Saul Modlin, MD's specialty? ▼
Saul Modlin, MD specializes in Otolaryngology Physician and practices in Garden City, New York. Credentials: MD.
How much does Saul Modlin, MD prescribe under Medicare Part D? ▼
In 2024, Saul Modlin, MD wrote 425 Medicare Part D claims totaling $81K in drug costs for 197 beneficiaries.
What is Saul Modlin, MD's Medicare quality score? ▼
Saul Modlin, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Saul Modlin, MD located? ▼
Saul Modlin, MD is located at 300 GARDEN CITY PLAZA, Garden City, NY, 11530. Phone: (516) 739-0333.
What is Saul Modlin, MD's NPI number? ▼
Saul Modlin, MD's National Provider Identifier (NPI) is 1013960210, issued on 05/18/2006.
Does Saul Modlin, MD prescribe more brand-name or generic drugs? ▼
Saul Modlin, MD's prescribing is 3% brand-name and 97% generic drugs by claim count, with $63K in brand drug costs.
How many Otolaryngology Physician providers are there in the US? ▼
There are 11,060 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 536 Medicare Part D claims per year.
What drugs does Saul Modlin, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Saul Modlin, MD's most frequently prescribed drugs include Ipratropium Bromide, Pantoprazole Sodium, Ofloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Saul Modlin, MD accept Medicare? ▼
Saul Modlin, MD appears in CMS Medicare data with 425 Part D claims and 197 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Saul Modlin, MD's credentials? ▼
Saul Modlin, MD's NPI is 1013960210 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.